Phase II study of SU5416 - A small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor - In patients with refractory myeloproliferative diseases

Francis J. Giles, Maureen A. Cooper, Lewis Silverman, Judith E. Karp, Jeffrey E. Lancet, Maurizio Zangari, Paul J. Shami, Khuda D. Khan, Alison L. Hannah, Julie M. Cherrington, Deborah A. Thomas, Guillermo Garcia-Manero, Maher Albitar, Hagop M. Kantarjian, Alison T. Stopeck

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of SU5416 - A small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor - In patients with refractory myeloproliferative diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences